Our findings herein suggest that intracranial injections of NDEVs isolated from individuals with DS-AD can elicit a neuroinflammatory response in the vicinity of the injection site, which may lead to both the propagation of neuroinflammation and the spread of toxic Tau forms. This evidence concerns the gene MAPT and Alzheimer disease.